Surgical Oncology
Volume 19, Issue 2 , Pages 106-113 , June 2010

Prognostic effect of different cut-off values (20mm, 30mm and 40mm) for clinical tumor size in FIGO stage IB cervical cancer

,Accepted 20 April 2009.

References 

  1. Creasman WT. New gynecologic cancer staging. Gynecol Oncol. 1995;58(2):157–158
  2. Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, et al. A comparison of stage IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?. Gynecol Oncol. 2004;95:70–76
  3. Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol. 2007;107:310–315
  4. Finan MA, DeCesare S, Fiorica JV, Chambers R, Hoffman MS, Kline RC, et al. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?. Gynecol Oncol. 1996;62:139–147
  5. Sevin BU, Nadji M, Lampe B, Lu Y, Hilsenbeck S, Koechli OR, et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer. 1995;76:1978–1986
  6. Kristensen GB, Abeler VA, Risberg B, Trope C, Bryne M. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol. 1999;74:245–251
  7. Wagenaar HC, Trimbos JB, Postema S, Anastasopoulou A, van der Geest RJ, Reiber JH, et al. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol. 2001;82:474–482
  8. Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB, Mortel R. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol. 1980;138:550–556
  9. Wagenaar HC, Trimbos JB, Postema S, Anastasopoulou A, van der Geest RJ, Reiber JH, et al. Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage 1B cervical cancer. Cancer. 1989;63:2220–2223
  10. Delgado G, Bundy BN, Fowler WC, Stehman FB, Sevin B, Creasman WT, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989;35:314–320
  11. Homesley HD, Raben M, Blake DD, Ferree CR, Bullock MS, Linton EB, et al. Relationship of lesion size to survival in patients with stage IB squamous cell carcinoma of the cervix uteri treated by radiation therapy. Surg Gynecol Obstet. 1980;150:529–531
  12. Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys. 1998;41:307–317
  13. Sardi J, Sananes C, Giaroli A, Bayo J, Rueda NG, Vighi S, et al. Results of a prospective trial with neoadjuvant chemotherapy in stage IB bulky, squamous carcinoma of the cervix. Gynecol Oncol. 1993;49(2):156–165
  14. Burghardt E, Pickel H. Local spread and lymph node involvement in cervical cancer. Obstet Gynecol. 1978;52:138–145
  15. Kamelle SA, Rutledge TL, Tillmanns TD, Gould NS, Cohn DE, Wright J, et al. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?. Gynecol Oncol. 2004;94:249–255
  16. Kovalic JJ, Perez CA, Grigsby PW, Lockett MA. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1991;21:905–910
  17. Lee JM, Lee KB, Park CY. Prognostic factors predicting survival in patients with FIGO stage IB cervical cancer treated surgically. Int J Gynaecol Obstet. 2006;94:143–144
  18. Comerci G, Bolger BS, Flannelly G, Maini M, de Barros Lopes A, Monaghan JM. Prognostic factors in surgically treated stage IB–IIB carcinoma of the cervix with negative lymph nodes. Int J Gynecol Cancer. 1998;8:23–26
  19. Trimbos JB, Lambeek AF, Peters AA, Wolterbeek R, Gaarenstroom KN, Fleuren GJ, et al. Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer. Gynecol Oncol. 2004;95:77–81
  20. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991;67:2776–2785

PII: S0960-7404(09)00058-9

doi: 10.1016/j.suronc.2009.04.004

Surgical Oncology
Volume 19, Issue 2 , Pages 106-113 , June 2010

Article Tools

* Image Usage & Resolution